FRAMINGHAM, Mass.--Genzyme Molecular Oncology here has received a US patent on its Serial Analysis of Gene Expression (SAGE) technology. The patent was issued to scientists at Johns Hopkins University from the laboratories of Kenneth Kinzler and Bert Vogelstein. The Genzyme division obtained an exclusive license to SAGE as a result of its parent company's acquisition of PharmaGenics last year.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.